Enschede's University of Twente drives a medtech and nanotech cluster with over 300 active startups, producing 60% more spinoffs per capita than the national benchmark. These firms have attracted €450 million in investment since 2021, with nanotech startups growing 35% faster than the average Dutch deep-tech company. Compared to #5 Utrecht, Enschede has 25% lower operational costs, and its medtech ventures achieve clinical trials 40% quicker than the industry norm. A standout: 1 in 3 spinoffs here holds an international patent.
Comments on "Enschede"
Create a free account or sign in to join the discussion.
Sign in to join the conversation